Sulfamide

Sulfamide

SCHEMBL3827754

NS(N)(=O)=O.[Ru]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfamide SCHEMBL5880 0.93
Sulfamide SCHEMBL3293102 0.86
Sulfamide SCHEMBL1000467 0.86
Sulfamide SCHEMBL10866319 0.86
Sulfamide SCHEMBL17495597 0.86
Sulfamide SCHEMBL3409127 0.86
Sulfamide SCHEMBL5067852 0.86
Sulfamide SCHEMBL5667325 0.86
Sulfamide SCHEMBL10866317 0.86
Sulfamide SCHEMBL9278069 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112457307-B Extraction method of R-quininol 河北省科学院生物研究所 2022-02-01 CN disclosed
CN-112457307-A Extraction method of R-quininol 河北省科学院生物研究所 2021-03-09 CN disclosed
EP-2078198-B1 USE OF CELL SURFACE DISPLAYS IN YEAST CELL CATALYST SUPPORTS ARCHER DANIELS MIDLAND CO (US) 2015-12-23 EP disclosed
US-8183030-B2 Saccharomyces cerevisiae receptor proteins; fusion proteins ARCHER DANIELS MIDLAND COMPANY (US) 2012-05-22 US disclosed
EP-2078198-A2 USE OF CELL SURFACE DISPLAYS IN YEAST CELL CATALYST SUPPORTS Archer-Daniels-Midland Company (US) 2009-07-15 EP disclosed
WO-2008063310-A2 USE OF CELL SURFACE DISPLAYS IN YEAST CELL CATALYST SUPPORTS ARCHER-DANIELS-MIDLAND COMPANY (US) 2008-05-29 WO disclosed
US-20080090282-A1 Use of cell surface displays in yeast cell catalyst supports ARCHER-DANIELS-MIDLAND COMPANY 2008-04-17 US disclosed
US-20080032964-A1 Process for the synthesis of azetidinone TEVA PHARMACEUTICALS USA, INC. 2008-02-07 US disclosed
CN-101104614-A Method of preparing (S)-dulouxetine key intermediate UNIV SUN YAT SEN (CN) 2008-01-16 CN disclosed